Clarity by Design
The iRhythm® cardiac monitoring service combines thoughtfully engineered devices, intelligent algorithms, and expert clinical review.
From seamless patient wear to physician-ready reports, every element works together to deliver precise answers when they matter most.
Clarity That Drives Confidence
Improved wear experience
Outstanding patient compliance
Continuous Monitoring
The Zio ECG monitoring service captures continuous cardiac data over extended wear periods — providing a comprehensive view of heart rhythm to support clinical evaluation.
More than a monitor
The iRhythm monitoring service delivers clarity at every step — from the moment a Zio® ECG monitor is prescribed and worn, through advanced AI-assisted analysis and expert review, to physician-ready, clinically actionable reports. With intuitive tools like the ZioSuite® portal and seamless EHR integration, the iRhythm monitoring service helps simplify workflows and bring meaningful insight to your practice.
How the Zio service works.
Interested in iRhythm Zio™ ambulatory ECG services?
Please contact your Senko Medical representative.
Incredible 99% physician agreement with end-of-wear reports
Zio® monitor IFU
Learn how to apply and use the Zio monitor.
- Data on file. iRhythm Technologies, 2023.
- Based on the US market data using Zio ECG monitors.
- Zio service provides continuous, uninterrupted recording and a comprehensive end-of-wear report.
- The Zio service facilitates a diagnosis as determined by a physician.
- Zio Monitor Instructions for Use. iRhythm Technologies.
- Battisti et al. Abstract 4141717: Feasibility of point-of-wear patient satisfaction surveys to validate patient-centered product enhancements: results from over 300,000 patients for long-term ambulatory cardiac monitoring. Circulation. 2024;150:A4141717. doi:10.1161/circ.150.suppl_1.4141717. https://www.ahajournals.org/doi/abs/10.1161/circ.150.suppl_1.4141717
- Based on US data.
- Data on file. iRhythm Technologies, 2024
- Based on US market data.
- Data on file. iRhythm Technologies, 2020.
- Hannun et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25:65-69. https://doi.org/10.1038/s41591-018-0268-3
- Deep learned algorithm is only available in the United States, European Union, Switzerland, United Kingdom, and Japan.
- FDA 510K clearance, CE mark, UKCA mark, and PMDA-approval.
- Data on file. iRhythm Technologies. 2026.